1 / 19

Prof. Ifeoma Okoye, President , Association for Good Clinical Practice in Nigeria (AGCPN)

Presented by. Prof. Ifeoma Okoye, President , Association for Good Clinical Practice in Nigeria (AGCPN) Professor of Radiology, College of Medicine, University of Nigeria, Nsukka & University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria

lana-ramsey
Download Presentation

Prof. Ifeoma Okoye, President , Association for Good Clinical Practice in Nigeria (AGCPN)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presented by Prof. Ifeoma Okoye, President, Association for Good Clinical Practice in Nigeria (AGCPN) Professor of Radiology, College of Medicine, University of Nigeria, Nsukka & University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria AFRICAN COORDINATOR OF CITI (Collaborative Institutional Training Initiative)

  2. ASSOCIATION FOR GOOD CLINICAL PRACTICE IN NIGERIA (AGCPN) • an initiative that has been promoting responsible conduct of Human Research and developing the infrastructure for clinical trials in Nigeria through government-regulatory body advocacy /media sensitisation, conferences and training workshops. • an umbrella organisation networking investigators/clinical trialists in Nigeria

  3. DEARTH OF INFLOW OF RCTS • 100,000 clinical trials are carried out worldwide each year, of the total; only about 10% of them is performed in the developing countries, 1% in Africa and very minimal fraction performed in Nigeria • Available data show that out of the 1600 clinical trials conducted in Africa only about 1% is placed in Nigeria as compared to about 50% placed in South Africa, 6% in Egypt, 55% in Uganda and 3.9% in Kenya. • Nigeria has not had significant HIV/AIDS trials like other countries in Eastern/Southern Africa

  4. Clinical Trial Capacity: Large Headroom in Africa Relatively low level of drug development activities in Africa

  5. Clinical Trial Capacity: Large Headroom in Nigeria Ample headroom for expansion

  6. Diseases Represented In Ongoing Clinical Trials In Nigeria Is A Reflection Of: Changing Disease Patterns Problems of reproductive health CNS Cardiovascular Acute infectious diseases Cancer Diseases of developed world Diseases of developing countries Diabetes Nutritional diseases Others Epidemiologic Transition

  7. 3 ACTIVITIES SINCE LAST CITI MTG

  8. Distribution of AGCPN members that are enrolled into the CITI Program. 4 INSTITUTIONS HAVE REGISTERED WITH CITI

  9. THE 4 REGISTERED INSTITUTIONS & the buy 4 get 1 free

  10. Reasons advanced for this poor compliance

  11. IDEALY AGCPN WOULD LIKE TO

  12. Participants at the opening ceremony of the Enugu ZonalToT As AGCPN continues its advocacy to influence political will and commitment of policy makers to Legislate and make mandatory RCR/GCP /Ethics/Bioethics Education for its research scientific community. Invest in strengthening agencies like regulatory bodies, National/Institutional Ethics committees, and GCP initiatives through properly voted BUDGETRY ALLOCATION

  13. HOW CAN YOU HELP?

  14. Table 1: Registered Clinical Trials in Nigeria. Data culled from http://clinicaltrials.gov.

  15. Table 1: Registered Clinical Trials in Nigeria. (Continued)

  16. Table 1: Registered Clinical Trials in Nigeria. (Continued)

  17. Table 1: Registered Clinical Trials in Nigeria. (Continued)

  18. THE TASK MAY APPEAR HERCULIAN BUT IT IS DOABLE WITH ALL HANDS ON DECK!

More Related